drugset
drugset / Trial / NCT05014919

Vortioxetine to Prevent Return of Symptoms in Children With Depression

NCT05014919 ↗

Phase 3 Terminated 35 enrolled H. Lundbeck A/S
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to find out if vortioxetine is better than placebo (sugar pills) in preventing depression in children who improved when treated with vortioxetine.

Timeline

Start
2021-08-10
Primary completion
2022-03-31
Completion
2022-04-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Vortioxetine Unknown 5 mg Oral
Subject Vortioxetine Unknown 10 mg Oral
Subject Vortioxetine Unknown 15 mg Oral
Subject Vortioxetine Unknown 20 mg Oral

Indications

depressive disorder